
- Telehealth Visits
- Insurance plan information

Kanade Shinkai, MD, PhD
Dermatology- Telehealth Visits
- Insurance plan information



Kanade Shinkai, MD, PhD
Dermatology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Kanade Shinkai is a dermatologist with expertise in caring for hospitalized, systemically ill patients. She sees patients with all types of skin disease but specializes in complex conditions, particularly autoimmune and autoinflammatory skin disorders.
In her research, Shinkai studies immunologic and inflammatory skin diseases.
Education & training
Board certification
- Dermatology, American Board of Dermatology
Residency
- Dermatology, UCSF School of Medicine -GME
Internship
- Internal Medicine, UCSF School of Medicine -GME
Degree
- MD, UCSF School of Medicine
Academic title
- Clinical Professor
My expertise
Specialties
Conditions
- Squamous Cell Carcinoma
- Melanoma
- Hyperhidrosis
- Eczema
- Skin Cancer
- Basal Cell Carcinoma
Locations
My research
Publications
Showing 1-6 of 138 reviews
- May 29, 20265 out of 5 Stars
My fear was heard. I will return for a body exam.
- May 28, 20265 out of 5 Stars
Dr.Shinkai is a excellent physician. She is incredibly thorough, professional, and warm in her interactions. Her depth of knowledge for overlapping medical issues is always impressive and helpful in making decisions regarding medication changes and ongoing medical care. I gladly drive 5 hours for follow-up care.
- May 18, 20265 out of 5 Stars
Good
- May 13, 20265 out of 5 Stars
Dr Shinkai is excellent!
- May 13, 20265 out of 5 Stars
She is an excellent physician. Very caring and supportive.
- May 8, 20265 out of 5 Stars
Dr Shinkai is outstanding in every way!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.